Location History:
- Bel Air, MD (US) (2004)
- Wilmington, DC (US) (2012)
- Abingdon, MD (US) (2010 - 2013)
- Wilmington, DE (US) (2013 - 2024)
Company Filing History:
13 out of 16 
1 out of 8,684 
Years Active: 2004-2024
Title: The Innovative Contributions of Dujie Qin in Polymer Science
Introduction
Dujie Qin, an accomplished inventor based in Wilmington, DE, has made significant advancements in the field of polymer science, amassing a portfolio of 14 patents. His work primarily focuses on the development of unique polymer aggregates that enhance the efficacy of pharmaceutical compounds.
Latest Patents
One of Dujie Qin's latest patents involves the creation of hydrophobic molecule-induced branched polymer aggregates. These aggregates are derived from both symmetrically and asymmetrically branched homopolymers that have been modified at the surface level to include functional groups. This modification enables the formation of aggregates with poorly water-soluble or water-insoluble pharmaceutically active agents (PAA). Notably, the aggregates that result from this interaction are distinct from those formed by either the polymer alone or the PAA alone. The aggregates serve to improve drug solubility, stability, delivery, and overall efficacy, showcasing Dujie Qin's innovative approach to solving challenges in drug formulation.
Career Highlights
Dujie Qin has held positions at notable companies such as Anp Technologies, Inc. and the United States of America, As Represented by the Secretary of the Army. His work in these organizations has contributed greatly to the development of advanced polymer technologies, fortifying his reputation as an expert in his field.
Collaborations
Throughout his career, Dujie Qin has collaborated with talented professionals, including Ray Yin and Jing Pan. These partnerships have enabled the exchange of ideas and contributed to the advancement of innovative research and development projects that support the pharmaceutical industry.
Conclusion
Dujie Qin's inventive efforts in polymer science and his ability to create functional aggregates represent a noteworthy contribution to the field. As he continues to explore and develop technologies that enhance drug delivery systems, his work will undoubtedly impact the pharmaceutical sector positively, paving the way for future innovations in healthcare.